AstraZeneca PLC (AZN)
158.78
-1.34
(-0.84%)
USD |
NYSE |
Oct 08, 16:00
159.70
+0.92
(+0.58%)
Pre-Market: 05:34
AstraZeneca 30-Day Average Daily Volume : 2.921M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 2.921M |
| October 07, 2026 | 2.894M |
| October 06, 2026 | 2.928M |
| October 05, 2026 | 2.952M |
| October 02, 2026 | 2.983M |
| October 01, 2026 | 3.051M |
| September 30, 2026 | 3.066M |
| September 29, 2026 | 3.092M |
| September 28, 2026 | 3.092M |
| September 25, 2026 | 3.157M |
| September 24, 2026 | 3.208M |
| September 23, 2026 | 3.240M |
| September 22, 2026 | 3.253M |
| September 21, 2026 | 3.301M |
| September 18, 2026 | 3.327M |
| September 17, 2026 | 3.304M |
| September 16, 2026 | 3.410M |
| September 15, 2026 | 3.551M |
| September 14, 2026 | 3.997M |
| September 11, 2026 | 3.950M |
| September 10, 2026 | 3.951M |
| September 09, 2026 | 3.928M |
| September 08, 2026 | 3.957M |
| September 04, 2026 | 3.914M |
| September 03, 2026 | 3.879M |
| Date | Value |
|---|---|
| September 02, 2026 | 3.878M |
| September 01, 2026 | 3.824M |
| August 31, 2026 | 3.803M |
| August 28, 2026 | 3.786M |
| August 27, 2026 | 3.756M |
| August 26, 2026 | 3.774M |
| August 25, 2026 | 3.782M |
| August 24, 2026 | 3.787M |
| August 21, 2026 | 3.850M |
| August 20, 2026 | 3.864M |
| August 19, 2026 | 3.916M |
| August 18, 2026 | 3.854M |
| August 17, 2026 | 3.825M |
| August 14, 2026 | 3.775M |
| August 13, 2026 | 3.731M |
| August 12, 2026 | 3.682M |
| August 11, 2026 | 3.631M |
| August 10, 2026 | 3.594M |
| August 07, 2026 | 3.577M |
| August 06, 2026 | 3.513M |
| August 05, 2026 | 3.514M |
| August 04, 2026 | 3.331M |
| August 03, 2026 | 3.111M |
| July 31, 2026 | 2.623M |
| July 30, 2026 | 2.629M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| GSK Plc | 3.712M |
| Johnson & Johnson | 6.661M |
| Eli Lilly & Co. | 2.348M |
| Merck & Co., Inc. | 9.401M |
| Novo Nordisk A/S | 13.33M |